Trial Profile
Efficacy and safety of luseogliflozin in patient with type 2 diabetes complicated with hepatic dysfunction
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Jan 2017
Price :
$35
*
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 25 Jan 2017 New trial record